Free tool
Stocks above their 200-day average
We cover 80 companies trading above their own 200-day average. The median market value in the group is $2.35B. Across the group, the median move over the past trading day is +0.08%. 100% of the 80 with a 200-day average trade above it. Price change over the past year runs from −15.4% to +136.2% across the middle 80 percent of the group, with a median of +21.3%.
Other lists in this group
Table
80 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% | Oct 27, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
| ABT | Abbott Laboratories | $114.10 | +6.37% | −7.08% | −11.83% | Oct 14, 2026 |
| DAP.DE | Danaher Corporation | 184.45 EUR | +4.06% | −5.68% | +6.90% | Oct 20, 2026 |
| DHR | Danaher Corporation | $215.36 | +8.19% | −6.33% | +5.61% | Oct 20, 2026 |
| MDT | Medtronic plc | $92.02 | +5.92% | −3.41% | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | 78.54 EUR | +1.19% | −2.78% | +2.65% | Sep 1, 2026 |
| ELV | Elevance Health, Inc. | $402.54 | +4.36% | +14.33% | +32.12% | Oct 21, 2026 |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% | Oct 22, 2026 |
| CNC | Centene Corporation | $65.47 | +2.44% | +56.70% | +127.01% | Oct 27, 2026 |
| DGX | Quest Diagnostics Incorporated | $245.00 | +3.84% | +42.24% | +38.12% | Oct 20, 2026 |
| INCY | Incyte Corporation | $128.12 | −1.39% | +26.33% | +51.01% | Oct 27, 2026 |
| WST | West Pharmaceutical Services, Inc. | $349.92 | +3.90% | +26.81% | +42.61% | Oct 22, 2026 |
| THC | Tenet Healthcare Corporation | $274.19 | +4.40% | +37.47% | +50.70% | Oct 27, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | 194.20 EUR | +13.30% | −7.09% | +11.32% | Oct 22, 2026 |
| MEDP | Medpace Holdings, Inc. | $619.05 | +8.42% | +8.41% | +30.74% | Oct 19, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% | Oct 27, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | 195.00 EUR | +9.92% | +0.74% | +21.79% | Oct 22, 2026 |
| EXEL | Exelixis, Inc. | $56.10 | −0.73% | +28.73% | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $126.35 | +13.31% | +28.91% | +42.93% | Oct 26, 2026 |
| ICLR | ICON Public Limited Company | $168.93 | −6.27% | −10.46% | −2.91% | Oct 21, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% | Oct 26, 2026 |
| MOH | Molina Healthcare, Inc. | $199.63 | −0.35% | +11.86% | +13.35% | Oct 21, 2026 |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% | Oct 21, 2026 |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% | Oct 27, 2026 |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% | Sep 4, 2026 |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% | Oct 27, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% | Oct 8, 2026 |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% | Oct 27, 2026 |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% | Oct 8, 2026 |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% | Oct 27, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% | Oct 1, 2026 |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% | Oct 27, 2026 |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% | Sep 29, 2026 |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% | Oct 21, 2026 |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% | Sep 29, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | 35.35 SEK | +1.58% | +15.22% | +12.01% | Oct 22, 2026 |
| EMBLA.CO | Embla Medical hf. | 30.15 DKK | +5.05% | −5.78% | −6.94% | Oct 20, 2026 |
| HCSG | Healthcare Services Group, Inc. | $22.91 | −3.54% | +32.05% | +47.05% | Oct 21, 2026 |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% | Oct 22, 2026 |
| KMTS | Kestra Medical Technologies, Ltd. | $26.57 | +11.36% | +8.94% | +47.61% | Sep 14, 2026 |
| INNV | InnovAge Holding Corp. | $11.04 | −6.52% | +112.72% | +178.79% | Sep 8, 2026 |
| GDS.PA | Ramsay Générale de Santé SA | 10.95 EUR | −0.45% | +17.24% | +9.50% | Oct 16, 2026 |
| 9627.T | Ain Holdings Inc. | 6,142.00 JPY | −2.57% | −5.73% | +2.85% | Sep 14, 2026 |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% | Sep 24, 2026 |
| 7730.T | Mani, Inc. | 1,607.00 JPY | +5.38% | +10.38% | +29.48% | Oct 15, 2026 |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% | Oct 22, 2026 |
| BBNX | Beta Bionics, Inc. | $19.34 | +22.41% | −33.88% | +1.95% | Oct 27, 2026 |
| MCAP.ST | MedCap AB (publ) | 554.50 SEK | +3.64% | +4.03% | −10.28% | Oct 23, 2026 |
| GNFT.PA | Genfit S.A. | 14.30 EUR | +5.30% | +172.38% | +310.45% | Sep 29, 2026 |
| ARJO-B.ST | Arjo AB (publ) | 28.38 SEK | +4.11% | −6.88% | −15.25% | Oct 22, 2026 |
| ANGO | AngioDynamics, Inc. | $15.69 | +9.41% | +23.74% | +56.74% | Oct 1, 2026 |
| MEDI.OL | Medistim ASA | 263.00 NOK | +16.37% | +4.43% | +4.43% | Oct 23, 2026 |
| NRC | NRC Health | $22.00 | −1.52% | +23.14% | +45.92% | Oct 26, 2026 |
| RZLT | Rezolute, Inc. | $5.04 | +2.44% | +132.79% | −30.00% | Sep 16, 2026 |
| BNTC | Benitec Biopharma Inc. | $12.88 | +8.33% | +2.34% | +0.16% | Sep 22, 2026 |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% | Sep 29, 2026 |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% | Aug 31, 2026 |
| HUM.ST | Humana AB (publ) | 71.70 SEK | +14.72% | +46.12% | +81.84% | Oct 22, 2026 |
| TRMED.OL | Thor Medical ASA | 6.76 NOK | +51.91% | +34.93% | +135.13% | Aug 28, 2026 |
| IPHA | Innate Pharma S.A. | $2.16 | +28.57% | +18.68% | +2.86% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | 1.88 EUR | +19.01% | +16.21% | +1.19% | Sep 17, 2026 |
| UTMD | Utah Medical Products, Inc. | $70.89 | −0.10% | +26.08% | +17.76% | Oct 22, 2026 |
| HITI | High Tide Inc. | $2.52 | +22.33% | −10.00% | −30.00% | Sep 14, 2026 |
| SEDANA.ST | Sedana Medical AB (publ) | 12.02 SEK | +23.92% | +12.13% | −22.05% | Oct 22, 2026 |
| ANIX | Anixa Biosciences, Inc. | $3.61 | +2.41% | +14.08% | +22.20% | Sep 9, 2026 |
| INTEG-B.ST | Integrum AB (publ) | 8.66 SEK | −0.92% | −16.73% | −79.55% | Sep 3, 2026 |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% | Sep 23, 2026 |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% | Oct 23, 2026 |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.